| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.38B | 24.97B | 22.57B | 20.45B | 18.25B | 17.68B |
| Gross Profit | 5.76B | 5.68B | 5.27B | 4.81B | 4.38B | 3.90B |
| EBITDA | 3.23B | 3.24B | 2.96B | 2.67B | 2.34B | 2.00B |
| Net Income | 2.34B | 2.37B | 2.11B | 2.21B | 1.63B | 1.36B |
Balance Sheet | ||||||
| Total Assets | 28.59B | 28.56B | 26.62B | 24.31B | 22.27B | 21.08B |
| Cash, Cash Equivalents and Short-Term Investments | 17.00B | 16.20B | 14.19B | 13.05B | 11.85B | 11.13B |
| Total Debt | 360.54M | 10.13M | 17.02M | 23.28M | 16.82M | 21.30M |
| Total Liabilities | 6.89B | 7.03B | 6.91B | 6.40B | 6.17B | 5.91B |
| Stockholders Equity | 21.70B | 21.53B | 19.71B | 17.91B | 16.10B | 15.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.57B | 1.83B | 2.06B | 1.62B | 2.09B |
| Operating Cash Flow | 0.00 | 2.77B | 1.85B | 2.09B | 1.65B | 2.15B |
| Investing Cash Flow | 0.00 | -506.84M | -121.89M | -1.21B | -318.93M | 329.07M |
| Financing Cash Flow | 0.00 | -302.26M | -582.60M | -267.83M | -617.69M | -258.77M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥29.00B | 16.05 | ― | 2.45% | 19.04% | 30.67% | |
72 Outperform | ¥25.77B | 9.67 | ― | 1.21% | 7.21% | 0.30% | |
71 Outperform | ¥23.86B | 11.39 | ― | 1.70% | 22.25% | 31.88% | |
69 Neutral | ¥32.99B | 13.32 | ― | 2.22% | 9.57% | 315.38% | |
68 Neutral | ¥28.60B | 11.13 | ― | 4.36% | 12.32% | 10.42% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
44 Neutral | ¥22.47B | -6.86 | ― | ― | 25.89% | -285.21% |